Aesthetic medicine is shifting away from predominantly corrective interventions and towards approaches that aim to support tissue regeneration and long-term structural integrity. Advances in the understanding of skin biology and extracellular matrix remodelling have contributed to the wider adoption of treatments that rely on endogenous repair mechanisms, including biostimulatory injectables, energy-based devices and controlled tissue injury techniques.1,2 

Despite encouraging clinical outcomes, variability in treatment response remains a recognised challenge, highlighting the need for more comprehensive assessment of biological factors that influence tissue readiness and regenerative capacity.3 Oxidative stress is a key contributor to cutaneous ageing and impaired wound healing. Reactive oxygen species (ROS) promote fibroblast dysfunction, the activation of matrix metalloproteinases and degradation of structural dermal proteins, while antioxidant defence systems are essential in maintaining redox balance and supporting tissue repair.4,5  

Importantly, antioxidant status is influenced by modifiable factors such as dietary intake, micronutrient supplementation and lifestyle behaviours, suggesting that aspects of the cellular environment relevant to regenerative outcomes may be amenable to optimisation.6  

This article explores the mechanistic relevance of antioxidant status in regenerative aesthetic medicine and considers how objective assessment may support treatment planning, patient preparation and response optimisation.  

Reactive oxygen species (ROS) and cutaneous ageing  

Oxidative stress is widely recognised as a central mechanism in both intrinsic and extrinsic skin ageing. ROS are generated through normal cellular metabolism as well as through environmental exposures, such as ultraviolet radiation, pollution and tobacco smoke.⁷ Excessive ROS production disrupts cellular homeostasis, leading to damage of lipids, proteins and nucleic acids, and contributes to progressive deterioration in dermal structure and function.8 

At the tissue level, oxidative stress has been shown to impair fibroblast proliferation and reduce the capacity for effective collagen synthesis.9 In parallel, ROS stimulate the expression of matrix metalloproteinases, promoting degradation of collagen and elastin fibres within the extracellular matrix.10 These processes contribute to dermal thinning, loss of tensile strength and reduced resilience of ageing skin. Oxidative damage also alters keratinocyte signalling and epidermal barrier recovery, further compromising cutaneous repair mechanisms.¹¹ 

Antioxidant defence systems and tissue repair  

Endogenous antioxidant systems, including enzymatic pathways such as superoxide dismutase and glutathione peroxidase, play a critical role in maintaining redox equilibrium.⁵ Dietary antioxidants provide an additional layer of defence by neutralising free radicals and modulating inflammatory signalling pathways involved in tissue remodelling.12  

Carotenoids in particular have demonstrated photoprotective and anti-inflammatory properties within the skin and have been associated with improved resistance to oxidative injury.13 Adequate antioxidant availability may therefore influence key biological processes relevant to regenerative aesthetic interventions, including inflammatory regulation, fibroblast activation and extracellular matrix synthesis.14 While these relationships are complex and influenced by multiple systemic factors, the balance between oxidative stress and antioxidant capacity represents a plausible contributor to variability in tissue healing and regenerative response.  

Regenerative treatment outcomes and biological variability  

Contemporary aesthetic practice incorporates treatments designed to stimulate endogenous regenerative pathways rather than provide immediate structural replacement. Biostimulatory injectables, energy-based devices and controlled tissue injury techniques aim to induce neocollagenesis, improve dermal matrix organisation and enhance overall tissue quality over time.15,16 

These interventions depend on coordinated inflammatory signalling, fibroblast activation and extracellular matrix remodelling, processes that typically evolve over several months following treatment.17 Although regenerative modalities have demonstrated clinical efficacy, treatment outcomes are variable. Differences in the magnitude and durability of collagen induction have been observed, reflecting the combined influence of procedural technique, treatment characteristics and individual biological variability.3  

Determinants of treatment response 

Intrinsic ageing is associated with reduced fibroblast density, diminished responsiveness to growth factors and altered inflammatory regulation, all of which may influence regenerative capacity.18 Systemic factors, including metabolic dysfunction, chronic low-grade inflammation and environmental exposures, further affect tissue repair processes and extracellular matrix turnover.19 Nutritional status also plays a recognised role in wound healing and collagen synthesis, with micronutrient deficiencies linked to delayed tissue recovery and impaired structural integrity.20  

Advanced skin analysis technologies are widely used in aesthetic practice to support consultation and treatment planning. These systems can provide objective information on parameters such as hydration, pigmentation patterns, vascular features and, in some cases, indicators of dermal density or inflammation.²¹  

While valuable for assessing visible and structural characteristics of skin health, they primarily reflect cutaneous presentation rather than underlying systemic influences that may affect regenerative response. Objective assessment tools capable of providing insight into broader physiological readiness for regenerative intervention remain limited in routine clinical settings. This presents a potential gap between the growing emphasis on mechanism-led treatment planning and the availability of practical measures that reflect biological factors influencing tissue repair.  

Treatment readiness and optimisation  

In surgical and rehabilitative medicine, optimisation of physiological status prior to intervention is recognised as a means of improving recovery and functional outcomes.20 Approaches such as nutritional support, metabolic conditioning and targeted lifestyle modification aim to enhance tissue resilience and healing potential.  

Applying similar principles within regenerative aesthetic practice may contribute to more predictable treatment trajectories, particularly for interventions dependent on collagen remodelling and controlled inflammatory responses. Recognition of modifiable biological variables influencing tissue readiness may therefore support refinement of personalised treatment planning and long-term outcome optimisation.  

Objective assessment of antioxidant status 

Although oxidative stress is recognised as an important contributor to cutaneous ageing and impaired tissue repair, its evaluation in routine aesthetic consultations remains largely indirect. Clinicians frequently rely on patient-reported lifestyle factors such as dietary habits, smoking status, ultraviolet exposure and perceived stress as surrogate indicators of systemic inflammatory burden.22  

Laboratory assessment of oxidative stress biomarkers is possible, but not routinely incorporated into aesthetic practice due to cost, accessibility and challenges in interpretation. Advances in optical technologies have enabled non-invasive estimation of antioxidant status through measurement of cutaneous carotenoid concentrations. Carotenoids are obtained exclusively from dietary sources and accumulate within the stratum corneum and subcutaneous tissue, contributing to photoprotection and modulation of oxidative processes.13 

Spectroscopic techniques have been developed to assess carotenoid levels in the skin. Raman-based methods detect characteristic molecular vibrational signatures, whereas reflection approaches provide indirect estimation based on tissue optical properties.23,24 

Devices utilising these principles are increasingly used in wellness and aesthetic settings to provide point-of-care insight into aspects of antioxidant status. These systems typically combine optical measurement with algorithm-based interpretation to contextualise individual results within broader population data. 

One example is the Prysm iO scanner (Nu Skin), a Raman-based optical device designed for integration into preventative health and aesthetic consultations. Its AI-driven analysis is trained on a large dataset derived from over two decades of biophotonic scanning, encompassing millions of individual measurements.  

Such technologies are generally intended to support patient education, facilitate discussion of modifiable lifestyle factors and enable longitudinal monitoring, rather than to establish diagnostic thresholds or independently determine treatment eligibility.25  

Cutaneous carotenoid measurement has been associated with dietary patterns, lifestyle behaviours and broader indicators of oxidative balance in population studies.26 Although it does not represent a comprehensive assessment of all antioxidant pathways, objective measurement may offer a practical adjunct in evaluating biological readiness for regenerative intervention. Interpretation should remain contextual and integrated with comprehensive clinical assessment, as clinically meaningful thresholds and direct correlations with aesthetic treatment outcomes have yet to be clearly established.  

Integration into regenerative aesthetic practice 

Objective assessment of antioxidant status may provide an additional dimension to aesthetic consultation by supporting evaluation of biological readiness for regenerative intervention. Considered alongside established clinical tools such as detailed medical history, lifestyle assessment, visual examination and advanced skin analysis technologies, measurement of cutaneous carotenoid levels may help identify patients who could benefit from optimisation strategies prior to treatment.  

Incorporating biomarker-informed discussion into consultation frameworks may also support shared decision-making and expectation management. Objective data relating to modifiable aspects of cellular health can encourage patient engagement in preparatory measures and promote a more proactive approach to treatment planning. Antioxidant status is influenced by dietary intake, micronutrient availability and lifestyle behaviours including sleep patterns, physical activity and exposure to environmental stressors.¹² 

Where reduced antioxidant capacity is suspected, clinicians may consider a period of physiological optimisation using nutritional supplementation before initiating regenerative procedures. Although direct evidence linking antioxidant optimisation to improved aesthetic outcomes remains limited, broader medical literature supports the importance of adequate micronutrient status in wound healing, collagen synthesis and inflammatory regulation.20  

Serial assessment of antioxidant status may provide a structured means of monitoring patient adherence to recommended lifestyle and supplementation interventions. Objective measurement can facilitate ongoing clinical dialogue and help determine whether the tissue environment is evolving in a manner supportive of regenerative change. Integration of measurable biological indicators into aesthetic practice may enhance patient understanding of the relationship between systemic health and skin ageing. This perspective aligns with increasing interest in preventative and longevity-focused care models, as well as broader trends towards self-monitoring and health optimisation.27,28 

Safety, clinical governance and limitations  

While objective assessment of antioxidant status may provide clinically useful insight into aspects of tissue biology, interpretation requires appropriate caution. Cutaneous carotenoid measurement represents an indirect indicator of redox balance and should be considered as one component within a broader clinical framework rather than a standalone determinant of treatment planning.24 

Measurement variability may be influenced by factors including recent dietary intake, supplementation practices, skin characteristics and device-specific methodological differences.29 

In addition, clinically meaningful threshold values that predict treatment response have not yet been clearly established. Further investigation is required to determine how changes in antioxidant status correlate with objective improvements in regenerative outcomes following aesthetic intervention.  

Future directions in biomarker-guided aesthetic medicine 

The developing emphasis on regenerative approaches reflects a broader shift towards integrating systemic health considerations into aesthetic treatment planning. As understanding of tissue biology continues to evolve, measurable physiological indicators such as oxidative stress, inflammatory status and metabolic health may contribute to more individualised therapeutic strategies.28  

Advances in non-invasive diagnostic technologies and longitudinal patient monitoring are likely to further influence how clinicians evaluate and optimise regenerative outcomes. Integration of biomarker data into consultation frameworks may support development of preventative care models focused on maintaining tissue function over time rather than addressing established structural change alone.27  

Conclusion  

Regenerative aesthetic interventions rely on complex biological processes including inflammatory signalling, fibroblast activation and extracellular matrix remodelling. Variability in patient response highlights the importance of considering systemic influences that may affect tissue repair capacity and long-term structural outcomes.  

Oxidative stress represents a biologically plausible contributor to this variability, and antioxidant defence mechanisms play a recognised role in maintaining cutaneous resilience and supporting healing pathways.3,14 Objective assessment of antioxidant status may therefore offer a clinically relevant adjunct to mechanism-led treatment planning, supporting patient engagement in modifiable health behaviours and facilitating a shift towards preventative, longevity-focused models of care.  

The expanding availability of non-invasive carotenoid scanning technologies such as the Raman-spectroscopy based device, Prysm iO, now being introduced into aesthetic practice, provides an opportunity to integrate measurable biological data into consultation frameworks.  

While current evidence does not yet present definitive clinical thresholds or causal relationships with treatment outcomes, continued research into biomarker-guided optimisation strategies may contribute to more personalised and predictable regenerative treatment paradigms. 

Disclaimer: Nikki Zanna is an affiliate of Nu Skin Enterprises, the manufacturer and distributor of Prysm iO.